Clinical Trial Update: Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating toremifene with or without atamestane for metastatic breast cancer in postmenopausal women has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Atamestane (atamestane)
• FARESTON (toremifene citrate)

Snippet

Sponsor: Intarcia Therapeutics | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED